ArticleCell stem cell2013

A Pan-BCL2 inhibitor renders bone-marrow-resident human leukemia stem cells sensitive to tyrosine kinase inhibition.

Daniel J Goff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.